Human FGFR1 _CD331 Protein Vector: HEK293
- Known as:
- Human FGFR1 _CD331 Protein Vector: HEK293
- Catalog number:
- 10111-H01H
- Product Quantity:
- 200μg
- Category:
- -
- Supplier:
- Provo
- Gene target:
- Human FGFR1 _CD331 Protein Vector: HEK293
Related genes to: Human FGFR1 _CD331 Protein Vector: HEK293
- Gene:
- FGFR1 NIH gene
- Name:
- fibroblast growth factor receptor 1
- Previous symbol:
- FLT2, KAL2
- Synonyms:
- H2, H3, H4, H5, CEK, FLG, BFGFR, N-SAM, CD331
- Chromosome:
- 8p11.23
- Locus Type:
- gene with protein product
- Date approved:
- 1992-02-25
- Date modifiied:
- 2019-04-23
Related products to: Human FGFR1 _CD331 Protein Vector: HEK293
Related articles to: Human FGFR1 _CD331 Protein Vector: HEK293
- The role of KMT5C varies across different tumor types, while its expression and function in prostate cancer remain largely unreported. This study investigated KMT5C expression in prostate cancer and its effects on tumor growth and immune response. - Source: PubMed
Publication date: 2026/05/13
Li ShuhangZhang LechaoYu Peng - Mounting evidence points to a potential link between statin therapy and erectile dysfunction (ED). However, the underlying mechanisms remain elusive, particularly concerning potential statin disruption of the inflammatory and immunofibrotic microenvironment within erectile tissue. This study sought to elucidate statin-associated ED and identify key molecular and cellular mediators driving this process. - Source: PubMed
Publication date: 2026/03/24
Zhang YangWen SongZhu YanpingZhang QinyongZheng PengyiWang XiaohuiLv Shuangwu - We report six intraductal papillary squamous neoplasms (IPSNs) of the pancreas, a rare but distinctive tumor whose biological features remain largely unknown. Five cases were investigated using an integrated approach combining histomorphological evaluation, immunohistochemistry, and multi-regional molecular profiling through whole-exome DNA sequencing and whole-transcriptome RNA sequencing. Only targeted DNA sequencing was available on a sixth recently diagnosed case. Histologically, the intraductal lesions were characterized by large, confluent papillae with fibrovascular cores lined by multilayered epithelial cells with diffuse squamous differentiation. All cases harbored a concomitant invasive carcinoma. The associated invasive carcinomas consistently included a tubular/ductal adenocarcinoma (PDAC); in five cases, a poorly differentiated squamous cell carcinoma (SCC) was also present, the proportion/features of which met the diagnostic criteria of adenosquamous carcinoma in two of them. Genomic analyses revealed that IPSNs and their matched invasive carcinomas shared the vast majority of somatic alterations, supporting a shared clonal origin for the two components. Activating KRAS mutations and biallelic inactivation of CDKN2A were detected in all cases. Recurrent mutations involved members of the SWI/SNF chromatin-remodeling complex and KMT2D. Additionally, FGFR1 and MYC amplifications were identified in two distinct cases (one case each). Molecular alterations restricted to the invasive component involved mediators of the TGF-β signaling pathway. Transcriptomic profiling demonstrated a basal-like expression pattern in all IPSNs and SCCs, while in two cases the matched PDAC shifted toward a classical transcriptomic subtype. In conclusion, through integrated histological assessment and multi-regional molecular sequencing, we demonstrate that IPSN represents a bona fide precursor of invasive pancreatic cancer, a new addition to the intraductal neoplasms category. This study challenges the current paradigm that pancreatic squamous epithelium plays no role in the initiation of pancreatic carcinogenesis, providing the first evidence of its involvement in early tumorigenic processes and yielding immediate implications for pancreatic tumor classification and biological understanding. - Source: PubMed
Publication date: 2026/05/12
Bevere MichelePea AntonioAdsay VolkanBasturk OlcaBrosens Lodewijk AEsposito IreneHruban Ralph HKlimstra DavidHong Seung-MoSinghi Aatur DLee Seung SooMattiolo PaolaPasini DavideMafficini AndreaPiccoli PaolaPedron SerenaCiulla CalogeroBrighenti AntoniettaFranzina CarlottaPaiella SalvatoreMalleo GiuseppeSalvia RobertoMilella MicheleDe Robertis RiccardoD'Onofrio MirkoCorbo VincenzoLawlor Rita TScarpa AldoLuchini Claudio - Cognitive frailty (CF), characterized by concurrent cognitive and motor decline, is a major challenge to healthy aging, yet effective interventions remain limited. Klotho, an anti-aging protein that declines with age, has been implicated in both hippocampal function and skeletal muscle homeostasis. In this study, we investigated whether aerobic exercise combined with multisensory stimulation training (CT) ameliorates age-related CF through systemic Klotho signaling. A 16-month-old mouse model of age-related CF was assigned to aerobic training, multisensory stimulation, or combined training, and behavioral, electrophysiological, histological, and molecular assessments were performed. To examine the mechanistic role of Klotho, dual-route shRNA delivery was used to inhibit systemic Klotho expression. CT significantly improved cognitive and motor performance compared with either intervention alone. CT also increased hippocampal dendritic spine density and long-term potentiation, reduced collagen deposition in gastrocnemius muscle, and upregulated Klotho, FGF19, and FGFR1 expression in both hippocampus and muscle, accompanied by elevated serum Klotho levels. Klotho knockdown attenuated these beneficial effects, reduced PSD95 and GluN2B expression, and increased MuRF3 and TNF-α levels. These findings suggest that CT alleviates cognitive frailty and that systemic Klotho is a key mediator linking hippocampal synaptic function and skeletal muscle homeostasis. - Source: PubMed
Publication date: 2026/04/29
Yang MinguangYe YuweiWang LiumuChi DongruiHu ZhongyiLin HuaweiChen LimingQiu YuxiDai YalingLi JianhongLiu WeilinTao JingChen Lidian - GBC is an aggressive biliary tract malignancy with limited survival. Although actionable genomic alterations (AGAs) are increasingly recognized in GBC, their prognostic association in real-world practice remains incompletely defined because genomic status is often confounded by stage at presentation and treatment selection. We evaluated the association between documented AGA status and overall survival (OS) using a tiered matching strategy to account for major clinical confounders. - Source: PubMed
Publication date: 2026/05/01
Solangi ZeeshanZambrano-Vera KatherinHaas LauraArciniegas Antonio JAgha ZinaShah GhulamAbbasi AhmedKristjanpoller WernerKozyreva OlgaRotellar FernandoVega Eduardo A